Ad
related to: current moderna stock price
Search results
Results From The WOW.Com Content Network
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. ... you may view the current stock price as an attractive entry point for a ...
This is the key reason Moderna stock is in a 90% drawdown. Nevertheless, artificial intelligence ... Moderna is an interesting opportunity for a turnaround bet at current prices. It isn't earning ...
Moderna’s revenue fell 64% to just below $7 billion in 2023 (far below the $18.5 billion in sales reported in 2020), and the company reported a loss of roughly $12 per share.
Moderna's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock price have been moving in the wrong direction for the past three years ...
If we assume Moderna only hits the low end of its 2025 revenue forecast, the stock trades at roughly 9 times forward sales. That's well above the 7.2 price-to-sales ratio for the biotech industry.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Going by the $127.69 average price target, the forecast is for an 18% drop in the coming months. ... (See Moderna stock analysis on TipRanks)To find good ideas for healthcare stocks trading at ...
Tuesday, Moderna Inc (NASDAQ:MRNA) stock is trading higher with a session volume of 8.0 million as per data from Benzinga Pro. On Friday, Moderna announced ongoing support from the U.S. Department ...